It was not possible to draw conclusions about associations between anti-VEGF treatment and obstetric complications due to the low numbers of reported cases and confounders from early-term miscarriages and inherently high-risk pregnancies in women with pre-existing diabetes. This evidence concerns the gene VEGFA and diabetes mellitus.